tirzepatide fibrosis Lilly touts win as it pads case for in MASH tirzepatide in mash the SYNERGY-NASH

The outlook for people with congenital heart disease depends on the type of issue and its severity

GLP-1 medications mimic a hormone that helps regulate blood sugar and appetite and have been used to treat type 2 diabetes for many years, and more recently, approved for weight loss

Noticeable body composition changes may occur

Retatrutide might fit non-diabetic adults with obesity whove failed other weight loss efforts

Tresiba extends well beyond that window, which means small variations in injection timing do not cause the dramatic blood sugar swings that can occur with shorter-duration basal insulins

Clinical trials showed 24.2% average weight loss at 48 weeks using the 12mg dose